IN2013MU03639A - - Google Patents

Info

Publication number
IN2013MU03639A
IN2013MU03639A IN3639MU2013A IN2013MU03639A IN 2013MU03639 A IN2013MU03639 A IN 2013MU03639A IN 3639MU2013 A IN3639MU2013 A IN 3639MU2013A IN 2013MU03639 A IN2013MU03639 A IN 2013MU03639A
Authority
IN
India
Prior art keywords
agomelatine
amorphous form
stable
stable amorphous
pharmaceutical composition
Prior art date
Application number
Inventor
Pankajkumar Maneklal Khapra
Dipankar DasuRanjan Bhadra
Hitesh Vaikunthbhai Thakkar
Rohan Aminbhai Lalani
Original Assignee
Alembic Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Pharmaceuticals Ltd filed Critical Alembic Pharmaceuticals Ltd
Priority to IN3639MU2013 priority Critical patent/IN2013MU03639A/en
Publication of IN2013MU03639A publication Critical patent/IN2013MU03639A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates pharmaceutical composition comprising stable amorphous form of Agomelatine for oral administration having improved in dissolution profile and process for preparing stable amorphous form of agomelatine which is stable under accelerated condition.
IN3639MU2013 2013-11-20 2013-11-20 IN2013MU03639A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3639MU2013 IN2013MU03639A (en) 2013-11-20 2013-11-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3639MU2013 IN2013MU03639A (en) 2013-11-20 2013-11-20

Publications (1)

Publication Number Publication Date
IN2013MU03639A true IN2013MU03639A (en) 2015-07-31

Family

ID=54397614

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3639MU2013 IN2013MU03639A (en) 2013-11-20 2013-11-20

Country Status (1)

Country Link
IN (1) IN2013MU03639A (en)

Similar Documents

Publication Publication Date Title
PH12016501122A1 (en) Delayed release compositions of linaclotide
EP3206706A4 (en) Stable injectable composition of pharmaceutically active agents and process for its preparation
PT3027186T (en) Process for the preparation of compositions comprising hyaluronic acid and mepivacaine hydrochloride
IN2013MU03583A (en)
MD20170048A2 (en) Abiraterone acetate formulation and methods of use
MX2018013742A (en) Crystal forms of crisaborole in free form and preparation method and use thereof.
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
MX2015011109A (en) Stable glucokinase activator compositions.
IN2013MU03641A (en)
MX2017015137A (en) Once daily oral pharmaceutical composition of isotretinoin.
MX2016006087A (en) Rapidly disintegrating formulations and methods of use.
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
EP3311809A4 (en) Use of pharmaceutical composition in preparation of drug for promoting chondrocyte generation
EP2978421A4 (en) Stable nanocomposition comprising docetaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
IL239958A0 (en) Chewable composition for oral administration and process for preparing thereof
IN2013MU01111A (en)
GB2527233A (en) Composition comprising hydrocortisone
IN2013CH04314A (en)
IN2013MU03428A (en)
IN2013MU03639A (en)
ZA201506665B (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
ZA201506656B (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters
IN2013MU01226A (en)
IN2013MU02111A (en)
IN2013MU02110A (en)